Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lever

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Nuclear Medicine and Biology|April 1, 1996
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121)J R Lever, U Scheffel, M Stathis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 1991
Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomographyB Sadzot, J C Price, H S Mayberg, et al.
Lab on a Chip|December 1, 2016
A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow controlJ R Coppeta, M J Mescher, B C Isenberg, et al.
The Journal of Biological Chemistry|September 3, 2014
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding siteRejwi Acharya Dahal, Akula Bala Pramod, Babita Sharma, et al.
Annals of Neurology|March 1, 1997
Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomographyI Madar, R P Lesser, G Krauss, et al.
Biochemical Pharmacology|July 24, 2017
Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogsDanielle Krout, Akula Bala Pramod, Rejwi Acharya Dahal, et al.
Chemmedchem|July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation InhibitorsUlf Hedström, Monica Norberg, Emma Evertsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2010
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificityNripen Chanda, Vijaya Kattumuri, Ravi Shukla, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 17, 2009
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing miceNripen Chanda, Para Kan, Lisa D Watkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancerRavi Shukla, Nripen Chanda, Ajit Zambre, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Nuclear Medicine and Biology|April 1, 1996
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121)J R Lever, U Scheffel, M Stathis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 1991
Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomographyB Sadzot, J C Price, H S Mayberg, et al.
Lab on a Chip|December 1, 2016
A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow controlJ R Coppeta, M J Mescher, B C Isenberg, et al.
The Journal of Biological Chemistry|September 3, 2014
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding siteRejwi Acharya Dahal, Akula Bala Pramod, Babita Sharma, et al.
Annals of Neurology|March 1, 1997
Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomographyI Madar, R P Lesser, G Krauss, et al.
Biochemical Pharmacology|July 24, 2017
Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogsDanielle Krout, Akula Bala Pramod, Rejwi Acharya Dahal, et al.
Chemmedchem|July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation InhibitorsUlf Hedström, Monica Norberg, Emma Evertsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2010
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificityNripen Chanda, Vijaya Kattumuri, Ravi Shukla, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 17, 2009
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing miceNripen Chanda, Para Kan, Lisa D Watkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancerRavi Shukla, Nripen Chanda, Ajit Zambre, et al.
Pageof 14